DecisionPoint Financial’s Eli Lilly LLY Stock Holding History

DecisionPoint Financial’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25.9K	Hold	28	–	–	0.01%	119
2025 Q4	$30.2K	Hold	28	–	–	0.01%	113
2025 Q3	$23.2K	Hold	28	–	–	0.01%	108
2025 Q2	$21.8K	Buy	28 +7	+33%	+$5.44K	0.01%	120
2025 Q1	$17.4K	Buy	21 +5	+31%	+$4.16K	0.01%	132
2024 Q4	$12.4K	Hold	16	–	–	﹤0.01%	148
2024 Q3	$14.2K	Hold	16	–	–	﹤0.01%	137
2024 Q2	$12.9K	Buy	16 +2	+14%	+$1.6K	﹤0.01%	145
2024 Q1	$10.3K	Hold	14	–	–	﹤0.01%	160
2023 Q4	$8.16K	Sell	14 -3	-18%	-$1.75K	﹤0.01%	139
2023 Q3	$9.13K	Hold	17	–	–	﹤0.01%	128
2023 Q2	$7.97K	Hold	17	–	–	﹤0.01%	124
2023 Q1	$5.84K	Hold	17	–	–	﹤0.01%	126
2022 Q4	$6.22K	Buy	+17	New	+$6.03K	﹤0.01%	107

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

DecisionPoint Financial's LLY Position: Q1 2026 in Review

DecisionPoint Financial held its Eli Lilly (LLY) position steady in Q1 2026 at 28 shares worth $25.9K. The position accounts for 0.01% of the portfolio, ranked #119.

DecisionPoint Financial first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $30.2K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

DecisionPoint Financial held 28 shares of Eli Lilly worth $25.9K as of Q1 2026.
DecisionPoint Financial left its Eli Lilly share count unchanged in Q1 2026.
Eli Lilly made up 0.01% of DecisionPoint Financial's portfolio in Q1 2026, its #119 holding.
DecisionPoint Financial first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
DecisionPoint Financial's Eli Lilly position peaked at $30.2K in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on DecisionPoint Financial's 13F filing for Q1 2026, filed 6 May 2026.